Loading...
Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea
VaxigripTetra® (Sanofi Pasteur, Lyon, France) is a quadrivalent split-virion inactivated influenza vaccine (IIV4) containing two B-lineage strains approved in the European Union and Taiwan in 2016 for individuals ≥ 3 years of age. Here, we describe an observer-blind, randomized, controlled, multicen...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861787/ https://ncbi.nlm.nih.gov/pubmed/28933625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1381808 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|